BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06040099-completion@plaintrial.com
DTSTAMP:20261029T083107Z
DTSTART;VALUE=DATE:20260701
SUMMARY:A US Study to Evaluate Transarterial Radioembolization (TARE) in Co
 mbination With Durvalumab and Bevacizumab Therapy in People With Unresecta
 ble Hepatocellular Carcinoma Amenable to TARE — estimated completion dat
 e
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06040099
URL:https://plaintrial.com/trial/NCT06040099
END:VEVENT
END:VCALENDAR